DRKS00023663已完成不适用
sability of the biomarker Midregional-proAdrenomedullin in children with congenital heart defect and surgical operation with use of a heart lung machine
niversita¨tsklinikum Heidelberg Zentrum fu¨r Kinder- und Jugendmedizin Kinderheilkunde II – Pa¨diatrische Kardiologie & Angeborene Herzfehler0 个研究点目标入组 150 人开始时间: 2020年11月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 5 Days 至 18 Years（—）
- 性别
- All
入选标准
- •Written and signed informed consent by the parents
- •Congential heart defect
- •elective corective surgery with use of a heart lung machine
- •5th day of live up to 18 years
排除标准
- •Non-Compliance to the including criteria’s
研究者
相似试验
招募中
Unknown
sing a blood test Adrenomedullin to predict disease severity andoutcome in patients with fever presenting to Emergency DepartmentCTRI/2023/07/054779Manipal Centre for Infectious Diseases (MACID)
尚未招募
不适用
Role of Midregional proadrenomedullin in detecting infection in newborn childreCTRI/2021/04/033251Sri Devaraj Urs Academy of Higher Education and Research
尚未招募
不适用
Mid-Range Proadenomedullin for prognosis in patients undergoing Emergency Laparotomy for Intestinal PerforatioCTRI/2021/10/037434AIIMS Rishikesh
招募中
不适用
Development of biomarker predicting the response of immunotherapy for patients with urothelial cancer using urine miRNAurothelial cancerJPRN-UMIN000047198Tokyo Medical University120
招募中
不适用
Pathophysiology and pathology diagnosis of adrenocortical disease causing aldosterone and cortisol excessJPRN-UMIN000024604Keio University500